Pharmadrug Inc. (TSE:PHRX) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PharmaDrug Inc. has announced a breakthrough in safe drug supply by filing a patent for a biosynthetic method to manufacture pharmaceutical grade cocaine, aiming to support harm reduction programs. The company’s initiative targets the development of a reliable and cost-effective production process that could revolutionize the supply chain for controlled substances. PharmaDrug is moving swiftly to develop this innovative method, which they believe will offer significant benefits to public health and provide a new revenue stream through global partnerships.
For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.